Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Endocrine 2Thoracic 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Neuroendocrine Tumors 131Pituitary Neoplasms 72Thyroid Cancer, Papillary 59Pheochromocytoma 55Multiple Endocrine Neoplasia Type 1 31Thyroid Neoplasms 30Paraganglioma 29Adrenal Gland Neoplasms 27Neoplasms 26Pancreatic Neoplasms 21Carcinoid Tumor 20Adrenocortical Carcinoma 19Hyperaldosteronism 17Cushing Syndrome 17Carcinoma, Neuroendocrine 17Gastro-enteropancreatic neuroendocrine tumor 16Acromegaly 15Pituitary Diseases 14Lung Neoplasms 13Stomach Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Carcinoma, Hepatocellular 11Breast Neoplasms 11Multiple Endocrine Neoplasia 10Melanoma 10Thyroid Carcinoma, Anaplastic 9Prolactinoma 9Lymphatic Metastasis 9Insulinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Essential Hypertension × Endocrine × Clear all
NCT06500000 2024-07-15

The Plasma Metabolomics Profiling of Primary Aldosteronism

Third Military Medical University

Completed
95 enrolled
Endocrine

Essential Hypertension, Hyperaldosteronism, Adrenocortical Adenoma

NCT06090617 2024-03-19

WHYSKI

University Hospital Padova

Unknown
35 enrolled
Endocrine

Essential Hypertension, Hyperaldosteronism, Hypertension, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡